Visual storyteller Taiwo Aina Adeokun spent several months traveling across Nigeria in 2025-2026, documenting parts of the country…

Italy’s Angelini Pharma has set its sights on the lucrative U.S. market, buying rare disease specialist Catalyst Pharmaceuticals and its…

A survey of more than 7,000 people in Australia, the UK and the US found that 3.2% of the population…

When Optimi Health launched its 2.5 million-share initial public offering (IPO) last month (PDF), the timing couldn’t have been better…

Following the surprise rejection in early 2026, the FDA agreed to reconsider the T-cell therapy based on the same single-arm…